Summary take home points by Dr Highland 1. PAH and PH-ILD are associated with high mortality in patients with SARDs 2. M
Summary take home points by Dr Highland 1. PAH and PH-ILD are associated with high mortality in patients with SARDs […]
Summary take home points by Dr Highland 1. PAH and PH-ILD are associated with high mortality in patients with SARDs […]
In this ph2 trial of LEVI-04 for knee #osteoarthritis, At wk 20, LEVI-04 ⬇️ bone marrow lesions (BML), greater ⬇
The CLASSIC study (n=1015, 27 countries) validated revised ASAS-SPARTAN axSpA criteria. Final model achieved 79.5% sensi https://pbs.twimg.com/profile_images/926606033270665216/Z42VohYE_normal.jpg john+RNV2@john… Mon, 10/27/2025
In the #ACR25 Great AI Debate, @RADoctor and @JYazdanyMD prepared independently, but in consecutive moments agree (in a https://pbs.twimg.com/profile_images/1659729373426241536/tnA2hRe4_normal.jpg john+RNV2@john…
#0854 @Official_ASAS & @SPARTAN_Updates revised #axSpA criteria meet targets: Sn 79.5% / Sp 90.4%. Imaging is centr https://pbs.twimg.com/profile_images/1489576716322447363/HmrVJtAH_normal.jpg john+RNV2@john… Mon,
#1627 SLR informing the 2025 @eular_org recommendations for PMR & LVV 🔍 141 studies (30 RCTs) reviewed: new & https://pbs.twimg.com/profile_images/1489576716322447363/HmrVJtAH_normal.jpg
#0853 Olink proteomics in anti-Ro+ pregnancies identifies macrophage-derived IL-6 & CCL3 as serum predictors of foet https://pbs.twimg.com/profile_images/1489576716322447363/HmrVJtAH_normal.jpg john+RNV2@john… Mon, 10/27/2025
Summary of (some) drugs in the pipeline for management of PAH. Slide credits: Dr Benjamin Freed @RheumNow #ACR2025 https://pbs.twimg.com/profile_images/1798008672708169728/8cvULQ3I_normal.jpg john+RNV2@john…
🎥 LIVE from #ACR25 Join us daily at 5 PM CST for RheumNow’s ACR Recap Live – Your must-watch debrief
Early Peripheral SpA: Is it okay to stop treatment sometimes? tammytilley@gm… Mon, 10/27/2025 – 09:52 Spondyloarthritis Dr. Richard Conway reports
Time for the 2nd plenary session! 🎤 #0849 GLP-1 receptor agonists in #PsA linked with lower mortality & fewer maj
In a global retrospective study of 90,536 PsA patients, those on GLP-1 receptor agonists (n=4,104) had significantly low https://pbs.twimg.com/profile_images/926606033270665216/Z42VohYE_normal.jpg john+RNV2@john…
GLP-1 RA meds: we are just starting to see their impact in rheumatoid arthritis. We know metabolic, CV risk in
This morning in the plenary, same theme, but in PsA: Similar metabolic/CV concerns Similarly benefit from GLP-1 RA look https://pbs.twimg.com/profile_images/1659729373426241536/tnA2hRe4_normal.jpg
Catching AxSpA Early: Closing the Diagnostic Gap tammytilley@gm… Mon, 10/27/2025 – 09:20 Spondyloarthritis Labs/Biomarkers Dr. Akhil Sood reports on abstract
Is Low Disease Activity Low Enough? tammytilley@gm… Mon, 10/27/2025 – 09:10 Rheumatoid Arthritis Drs. Jonathan Kay and Joel Kremer discuss
Should we be using JAKi more in female SpA patients? drrichardconwa… Mon, 10/27/2025 – 08:45
Key slide and takeaways on the ACR 2025 extrarenal SLE guideline. Presented by Lisa Sammaritano @RheumNow #ACR25 #ACRBes https://pbs.twimg.com/profile_images/926606033270665216/Z42VohYE_normal.jpg john+RNV2@john…
New Research Demonstrates Impact of RISE Registry Data on Rheumatology Outcomes tammytilley@gm… Mon, 10/27/2025 – 08:15
Rheumatology’s Blind Spot: The Persistent Exclusion of Older Adults leefam59@gmail.com Mon, 10/27/2025 – 08:30
Crisci et al. from CorEvitas. Alcohol, esp moderate use, associated lower CDAI. Most likely explanation appears to be re https://pbs.twimg.com/profile_images/1389468430160510976/sooz0Ud3_normal.jpg
Upadacitinib is a Double Edged Vascular Sword in GCA tammytilley@gm… Sun, 10/26/2025 – 23:41 Education/ACR/EULAR Anti-Rheumatic Rx Labs/Biomarkers Steroids Vasculitis
#ACR25 Abstr#0773 Anti-MDA5 ab is assoc. with progressive DM-ILD. But MDA5 expression is also upregulated in IPF. Any ne https://pbs.twimg.com/profile_images/1625445768768135171/M24lCgC__normal.jpg
What is the #frequency of #CTD #ILD in #USA? Data from #Marketscan >9K & #Optum ~20k CTD-ILD Pts 56-65 yrs,
Increased risk of psoriatic arthritis with obesity. A preview to Abstract#2687 Scher J @RheumNow #ACR25 https://t.co/cMb https://pbs.twimg.com/profile_images/926606033270665216/Z42VohYE_normal.jpg john+RNV2@john… Sun, 10/26/2025
AI Scribes Found their Favorite Doctors tammytilley@gm… Sun, 10/26/2025 – 20:53 Education/ACR/EULAR General Rheumatology Dr. Aurelie Najm discusses abstract 0189,